皮肤镜联合手持反射式共聚焦显微镜对头颈部基底细胞癌的前瞻性亚型分型
本研究为单中心前瞻性配对诊断比较研究,纳入340例肉眼疑似头颈部基底细胞癌(BCC)的皮损,评估皮肤镜联合手持反射式共聚焦显微镜(HH-RCM)诊断及亚型分型的准确性。结果显示联合成像对BCC总体诊断敏感性97.5%、特异性85.2%,在高诊断信心病例中分别提升至98.8%和94.1%;活检亚型与切除标本不一致率达33%。联合成像可减少不必要的诊断性活检,并可能在高诊断信心且计划行显微控制手术时替代确认性活检。
要点
- 皮肤镜联合HH-RCM诊断头颈部BCC总体敏感性97.5%、特异性85.2%。
- 高诊断信心时敏感性98.8%、特异性94.1%,可减少不必要活检。
- 活检亚型与切除标本不一致率33%,联合成像亚型分型仍不足以替代全部活检。
核心结论
- 皮肤镜联合HH-RCM诊断可显著减少不必要的诊断性活检。
- 在考虑显微控制手术时,该无创路径可能替代头颈部BCC的确认性活检。
研究设计与样本
- 前瞻性、单中心、配对诊断比较研究,连续纳入340例肉眼疑似BCC的头颈部皮损。
- 所有皮损均行皮肤镜和HH-RCM检查,随后行活检及手术切除。
- 诊断信心采用3点Likert量表记录。
主要发现
- 活检亚型与切除标本不一致的病例占33%。
- 联合皮肤镜-HH-RCM诊断BCC总体敏感性97.5%(95%CI:95.0-99.0),特异性85.2%(95%CI:72.9-93.4)。
- 高诊断信心病例中敏感性98.8%(95%CI:96.5-99.7),特异性94.1%(95%CI:80.3-99.3)。
- 检测非浅表型BCC的敏感性和特异性分别为95.5%(95%CI:92.9-98.1)和44.8%(95%CI:26.7-62.9)。
- 检测浸润型BCC的敏感性58.8%(95%CI:45.3-72.3),特异性79.6%(95%CI:74.3-84.9)。
关键数值与推荐
- 在高诊断信心亚组(n=281)中假想应用国际Mohs显微描记手术(MMS)标准,仅≤0.7%(n=2)的良性病变会被切除。
临床怎么用
- 皮肤镜联合HH-RCM可用于头颈部BCC的无创诊断,减少不必要的诊断性活检。
- 在高诊断信心且计划行显微控制手术时,可考虑以该联合成像替代确认性活检。
- 联合成像对BCC亚型分型准确性有限,尤其检测浸润型BCC敏感性仅58.8%,仍需谨慎用于治疗决策。
局限性
- 研究为单中心设计。
- 亚型分型特异性较低,尤其非浅表型BCC特异性44.8%。
- 高诊断信心亚组中MMS标准的应用为假想分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The management of head and neck basal cell carcinoma (BCC) relies on diagnostic biopsies. However, substantial discordance exists between biopsy and excisional specimens. Handheld reflectance confocal microscopy (HH-RCM) could reduce invasive biopsies. OBJECTIVES: The primary objective was to assess the diagnostic accuracy of combined dermoscopy and HH-RCM for diagnosing and subtyping primary head and neck BCC. The secondary objective was to determine the outcome when applying international Mohs micrographic surgery (MMS) criteria to this diagnostic pathway. METHODS: We conducted a prospective, single-centre, paired diagnostic comparison study. Diagnostic confidence was recorded using a 3-point Likert scale for all outcomes. RESULTS: A total of 340 consecutive lesions suspected of being BCC by the naked eye were included. Biopsy subtypes were found to be inconsistent with excisional specimens in 33% of cases. Combined dermoscopy-HH-RCM demonstrated an overall BCC diagnostic sensitivity of 97.5% (95% CI: 95.0-99.0) and a specificity of 85.2% (95% CI: 72.9-93.4). In cases where diagnostic confidence was high, sensitivity improved to 98.8% (95% CI: 96.5-99.7) and specificity to 94.1% (95% CI: 80.3-99.3). For BCC subtyping, the sensitivity and specificity for detecting non-superficial BCC were 95.5% (95% CI: 92.9-98.1) and 44.8% (95% CI: 26.7-62.9), respectively. For detecting infiltrative BCC, sensitivity was 58.8% (95% CI: 45.3-72.3), and specificity was 79.6% (95% CI: 74.3-84.9). Hypothetically applying international MMS criteria to the subset of our cohort with high diagnostic confidence (n = 281) would have resulted in the excision of ≤0.7% (n = 2) of benign lesions. CONCLUSIONS: Dermoscopy HH-RCM diagnosis significantly reduces unnecessary diagnostic biopsies. It could potentially replace confirming biopsies in managing head and neck BCC when considering micrographically controlled surgery. Basal cell carcinoma is the most common type of skin cancer and often appears on the head and neck, where it can affect both cosmetics and function. Different subtypes of this cancer behave differently and may need different treatments. This study was carried out at the Netherlands Cancer Institute in Amsterdam, the Netherlands. The aim of this study was to find out whether two non‐invasive imaging techniques, dermoscopy (a magnifying light device) and handheld reflectance confocal microscopy (a laser‐based imaging tool that shows skin cells in detail), can accurately diagnose and classify basal cell carcinomas of the head and neck without the need for a tissue sample (biopsy). 340 skin lesions in the head or neck suspicious for basal cell carcinoma on visual inspection. All lesions were examined with dermoscopy and handheld reflectance confocal microscopy, and then a small biopsy and subsequent surgical removal were performed. Dermoscopy plus handheld reflectance confocal microscopy identified basal cell carcinoma with high accuracy, reaching a sensitivity of about 99% and a specificity of about 94% in lesions where doctors felt highly confident in their imaging‐based diagnosis. The combined imaging approach also helped distinguish between less aggressive and more aggressive subtypes but was insufficient to replace all biopsies. In selected higher risk situations, such as when planning micrographically controlled surgery (Mohs surgery), this non‐invasive approach may likely safely guide treatment decisions while sparing patients an additional invasive procedure.
引用
- Elshot YS, Ouwerkerk W, Zupan-Kajcovski B, et al. Prospective subtyping of head and neck basal cell carcinoma by dermoscopy and handheld RCM. J Eur Acad Dermatol Venereol. 2026. PMID: 42517723. doi:10.1111/jdv.70647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。